ГоловнаArchive of numbers2016Volume 24, issue 2 (87)The analysis of motives of refusal from maintenance antipsychotic therapy among the patients with paranoid schizophrenia, combined with the cannabinoids, using during the fi rst remission
Title of the article The analysis of motives of refusal from maintenance antipsychotic therapy among the patients with paranoid schizophrenia, combined with the cannabinoids, using during the fi rst remission
Authors Skrypnikov Andrii
Kydon Pavlo
In the section DIAGNOSTICS AND THERAPY OF MENTAL AND NARCOLOGICAL DISORDERS
Year 2016 Issue Volume 24, issue 2 (87) Pages 88-90
Type of article Scientific article Index UDK 616-036.62:[616.895.87-06:616.89-008.441.13-085.214-036.66] Index BBK -
Abstract The aim of this study was to determine the motives of the refusal from maintenance antipsychotic therapy in patients with paranoid schizophrenia, combined with the cannabinoids using during fi rst remission of schizophrenic process. There were examined 173 patients with paranoid schizophrenia, which were divided into two clinical groups. The study included clinicalpsychopathological examination, organized in the semi-structured clinical interview form. It was revealed that motives of refusing from maintenance antipsychotic therapy in patients with paranoid form of schizophrenia with concomitant using of cannabinoids and patients without addictive pathology are diff erent, which may be used in the development of preventive and rehabilitation measures during the fi rst remission in such patients.
Key words motives, antipsychotic therapy, paranoid schizophrenia, cannabinoids
Access to full text version of the article pdf download
Bibliography 1. Афанасьева А. В. Особенности употребления психоактивных веществ больными шизофренией и его влияние на течение шизофренического процесса (Обзор литературы) / А. В. Афанасьева // Український вісник психоневрології. — 2011. — № 3. — С. 82—85.
2. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts 1969: historical cohort study / S. Zammit P. Allebeck, S. Andreasson [et al.] // British medical journal. — 2002. — № 35. — P. 1199—1201.
3. Causal association between cannabis and psychosis: examination of the evidence / [L. Arseneault, M. Cannon, J. Witton, R. M. Murray] // The British Journal of Psychiatry. — 2004. — № 184. — Р. 110—117. 4. Мосолов С. Н. Валидизация стандартизированных клинико-функциональных критериев ремиссии при шизо фре нии / С. Н. Мосолов, А. В. Потапов А. А. Шафаренко // Социальная и клини чес кая психиатрия. — 2011. — № 3. — С. 36—42.
5. Мотивы отказов больных шизо фре нией от длительной антипсихоти чес кой терапии / [А. С. Аведисова, Д. В. Ястребов, В. И. Бородин, Г. К. Дашкина] // Психиатрия и психофармако- терапия. — 2009. — № 2. — С. 6—13.
6. Зюзін В. О. Статистичні методи в охороні здоров’я та медицині / В. О. Зюзін, А. В. Костріков, В. Л. Філатова. — Полтава : [б. в.], 2002. — 150 с.